Development of continuous implantable renal replacement: past and future.
暂无分享,去创建一个
Shuvo Roy | William H Fissell | Aaron J Fleischman | A. Fleischman | Shuvo Roy | W. Fissell | H David Humes | H. Humes | H. Humes
[1] H D Humes,et al. Tissue engineering of a bioartificial renal tubule assist device: in vitro transport and metabolic characteristics. , 1999, Kidney international.
[2] S. M. MacKay,et al. Replacement of renal function in uremic animals with a tissue-engineered kidney , 1999, Nature Biotechnology.
[3] Christopher T. Chan,et al. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. , 2002, Kidney international.
[4] Anthony Atala,et al. Tissue engineering, stem cells, and cloning: opportunities for regenerative medicine. , 2004, Journal of the American Society of Nephrology : JASN.
[5] C. S. Chen,et al. Geometric control of cell life and death. , 1997, Science.
[6] Shuvo Roy,et al. Differentiated Growth of Human Renal Tubule Cells on Thin-Film and Nanostructured Materials , 2006, ASAIO journal.
[7] Mark E Meyerhoff,et al. Polymers incorporating nitric oxide releasing/generating substances for improved biocompatibility of blood-contacting medical devices. , 2005, Biomaterials.
[8] E. Mancini,et al. Convective and adsorptive removal of beta2-microglobulin during predilutional and postdilutional hemofiltration. , 2005, Kidney international.
[9] C Ronco,et al. Nanoscale Modulation of the Pore Dimensions, Size Distribution and Structure of a new Polysulfone-Based High-Flux Dialysis Membrane , 2001, The International journal of artificial organs.
[10] A. Fleischman,et al. A System for Micro/Nano Fluidic Flow Diagnostics , 2005, Biomedical microdevices.
[11] Véronique Sébille,et al. Effect of Treatment With Low Doses of Hydrocortisone and Fludrocortisone on Mortality in Patients With Septic Shock , 2002 .
[12] Ingrid Ledebo,et al. Convective Dialysis Therapies, Current Status and Perspective , 2005, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[13] Y. Qiu,et al. Biomimetic engineering of non-adhesive glycocalyx-like surfaces using oligosaccharide surfactant polymers , 1998, Nature.
[14] J Ean,et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.
[15] G. Whitesides,et al. Cell shape provides global control of focal adhesion assembly. , 2003, Biochemical and biophysical research communications.
[16] C. Ronco,et al. The Human Nephron Filter: Toward a Continuously Functioning, Implantable Artificial Nephron System , 2005, Blood Purification.
[17] Feng Lin,et al. The Incidence of End-Stage Renal Disease Is Increasing Faster than the Prevalence of Chronic Renal Insufficiency , 2004, Annals of Internal Medicine.
[18] Christopher T. Chan,et al. Quotidian dialysis – update 2005 , 2005, Current opinion in nephrology and hypertension.
[19] G. Nesrallah,et al. Calcium and phosphate balance with quotidian hemodialysis. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[20] J. Díaz-Buxó,et al. Home Hemodialysis and Remote Monitoring: Current Technology, Requirements and Capabilities , 2004, Blood Purification.
[21] S. Jacobsen,et al. Combined technological-clinical approach to wearable dialysis. , 1978, Kidney international. Supplement.
[22] Hans-Dietrich Polaschegg,et al. Continuous Renal Replacement Therapy for End-Stage Renal Disease , 2005 .
[23] Alexander Papra,et al. Characterization of ultrathin poly(ethylene glycol) monolayers on silicon substrates , 2001 .
[24] Mehmet Toner,et al. Blood-on-a-chip. , 2005, Annual review of biomedical engineering.
[25] Y J Kim,et al. Surface characterization and in vitro blood compatibility of poly(ethylene terephthalate) immobilized with insulin and/or heparin using plasma glow discharge. , 2000, Biomaterials.
[26] C. Wanner,et al. Beta2-microglobulin removal by extracorporeal renal replacement therapies , 2005 .
[27] L. Moist,et al. Patient quality of life on quotidian hemodialysis. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[28] Edward F Leonard,et al. Membraneless dialysis--is it possible? , 2005, Contributions to nephrology.
[29] William F Weitzel,et al. Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. , 2004, Kidney international.
[30] K. Leunissen,et al. Pre-dilution on-line haemofiltration vs low-flux haemodialysis: a randomized prospective study. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[31] Humes Hd,et al. Bioartificial kidney for full renal replacement therapy. , 2000 .
[32] Edward F. Leonard,et al. Dialysis without Membranes: How and Why? , 2004, Blood Purification.
[33] Allen R Nissenson,et al. Continuously functioning artificial nephron system: The promise of nanotechnology , 2005, Hemodialysis international. International Symposium on Home Hemodialysis.
[34] Tejal A Desai,et al. Nanoporous microsystems for islet cell replacement. , 2004, Advanced drug delivery reviews.
[35] David Haber,et al. Guide to clinical preventive services: a challenge to physician resourcefulness , 1993 .
[36] B. Haraldsson,et al. Glomerular size and charge selectivity in the rat as revealed by FITC-ficoll and albumin. , 2000, American journal of physiology. Renal physiology.